We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
-9.55%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.91B
AUM Growth
-$872M
Cap. Flow
-$3.53M
Cap. Flow %
-0.05%
Top 10 Hldgs %
70.94%
Holding
141
New
10
Increased
20
Reduced
67
Closed
19

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$333M
2
PG icon
Procter & Gamble
PG
+$47.1M
3
CVS icon
CVS Health
CVS
+$42.1M
4
USB icon
US Bancorp
USB
+$40.8M
5
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$10.8M

Top Sells

Rank Stock Value
1
C icon
Citigroup
C
+$355M
2
CL icon
Colgate-Palmolive
CL
+$27M
3
V icon
Visa
V
+$19.2M
4
ESRX
Express Scripts Holding Company
ESRX
+$9.59M
5
BMY icon
Bristol-Myers Squibb
BMY
+$7.46M

Sector Composition

Rank Sector Weight
1 Financials 22.69%
2 Consumer Discretionary 16.64%
3 Healthcare 14.3%
4 Communication Services 12.68%
5 Consumer Staples 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVAX
51
DELISTED
Dynavax Technologies
DVAX
$4.49M 0.06%
490,363
-55,352
-10% -$613K
EXAS
52
DELISTED
Exact Sciences
EXAS
$4.31M 0.06%
68,331
-24,241
-26% -$1.66M
COLL icon
53
Collegium Pharmaceutical
COLL
$1.17B
$4.05M 0.06%
236,021
-83,729
-26% -$1.43M
JAZZ icon
54
Jazz Pharmaceuticals
JAZZ
$16.1B
$3.98M 0.06%
32,064
-17,871
-36% -$2.65M
SRPT icon
55
Sarepta Therapeutics
SRPT
$1.64B
$3.82M 0.06%
34,968
-12,078
-26% -$1.51M
HZNP
56
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$3.74M 0.05%
191,544
-159,805
-45% -$3.13M
LHCG
57
DELISTED
LHC Group LLC
LHCG
$3.54M 0.05%
37,657
-13,359
-26% -$1.28M
XENT
58
DELISTED
Intersect ENT, Inc
XENT
$3.48M 0.05%
123,514
-43,819
-26% -$1.28M
HRTX icon
59
Heron Therapeutics
HRTX
$92.4M
$3.41M 0.05%
131,598
-46,685
-26% -$1.28M
DXCM icon
60
DexCom
DXCM
$29.1B
$3.23M 0.05%
107,796
-38,244
-26% -$1.21M
AIMT
61
DELISTED
Aimmune Therapeutics
AIMT
$3.21M 0.05%
134,332
-73,850
-35% -$1.91M
PTLA
62
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3.11M 0.05%
159,366
-64,316
-29% -$1.32M
AERI
63
DELISTED
Aerie Pharmaceuticals
AERI
$2.92M 0.04%
81,015
-27,251
-25% -$1.28M
TDOC icon
64
Teladoc Health
TDOC
$1.66B
$2.88M 0.04%
+58,007
New +$3.55M
INCY icon
65
Incyte
INCY
$25.3B
$2.83M 0.04%
44,479
-2,544
-5% -$165K
GKOS icon
66
Glaukos
GKOS
$9.2B
$2.77M 0.04%
49,275
-17,032
-26% -$1.02M
TXMD icon
67
TherapeuticsMD
TXMD
$23.7M
$2.67M 0.04%
+14,038
New +$3.42M
ISRG icon
68
Intuitive Surgical
ISRG
$127B
$2.62M 0.04%
+16,416
New +$2.78M
GWPH
69
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$2.5M 0.04%
25,702
-8,386
-25% -$1.1M
PRTK
70
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2.41M 0.03%
470,150
-38,132
-8% -$290K
AQN icon
71
Algonquin Power & Utilities
AQN
$4.66B
$2.31M 0.03%
167,900
– –
AY
72
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$2.29M 0.03%
116,569
+30,335
+35% +$601K
T icon
73
AT&T
T
$167B
$2.2M 0.03%
102,238
+28,965
+40% +$674K
DERM
74
DELISTED
Dermira, Inc.
DERM
$2.18M 0.03%
302,952
-104,819
-26% -$1.15M
CCI icon
75
Crown Castle
CCI
$33.2B
$2.16M 0.03%
19,900
– –
1 2
3
4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q4 2018 Portfolio in Review

As of Q4 2018, C WorldWide Group held 141 positions worth $6.91B, down 11% from $7.79B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

C WorldWide Group's Q4 2018 filing shows 10 new, 20 increased, 67 reduced and 19 closed positions. Its largest new stake was American Tower: 2,128,357 shares worth $337M. The largest sale was Citigroup, an estimated $355M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • C WorldWide Group's largest Q4 2018 buy was American Tower: 2,128,357 shares worth $337M.
  • C WorldWide Group added most to Procter & Gamble in Q4 2018, an estimated $47.1M increase.
  • C WorldWide Group's biggest Q4 2018 reduction was Visa, cutting an estimated $19.2M.
  • C WorldWide Group fully exited Citigroup in Q4 2018, selling an estimated $355M.
  • C WorldWide Group's ten largest holdings make up 71% of its $6.91B portfolio in Q4 2018.
  • C WorldWide Group opened 10 new positions and closed 19 in Q4 2018.
  • C WorldWide Group's portfolio value fell 11% quarter-over-quarter to $6.91B.

Based on C WorldWide Group's 13F filing for Q4 2018, filed 12 Feb 2019.